VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 3 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $984,000 | -25.0% | 42,350 | -48.6% | 0.46% | -25.4% |
| Q1 2018 | $1,312,000 | +465.5% | 82,416 | +6239.7% | 0.62% | +558.5% |
| Q3 2015 | $232,000 | -19.7% | 1,300 | 0.0% | 0.09% | +1.1% |
| Q2 2015 | $289,000 | -36.8% | 1,300 | -43.5% | 0.09% | -16.2% |
| Q1 2015 | $457,000 | +62.1% | 2,300 | -4.2% | 0.11% | +362.5% |
| Q4 2013 | $282,000 | -50.0% | 2,400 | -55.6% | 0.02% | -44.2% |
| Q3 2013 | $564,000 | +21.0% | 5,410 | 0.0% | 0.04% | +10.3% |
| Q2 2013 | $466,000 | -87.0% | 5,410 | -88.7% | 0.04% | -84.5% |
| Q1 2013 | $3,577,000 | +264.3% | 47,680 | +152.3% | 0.25% | +445.7% |
| Q2 2011 | $982,000 | – | 18,900 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |